News
Smart Portfolio
Markets
undefined
Research Tools
Research Tools
Top Stocks
Top Smart Score Stocks
New
Analysts' Top Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Daily Feeds
Daily Stock Ratings
Daily Insider Transactions
Screeners
Stock Screener
New
Stock Comparison
New
Smart Portfolio
Smart Portfolio
My Portfolio
Overview
My Holdings
My Portfolio Analysis
Crowd Insights
My Community
My Performance
My Public Profile
New
Top Experts
Top Experts
Find & Follow Experts
My Experts
Expert Center
Top Firms
Top Lists
Top 25 Wall Street Analysts
Top 25 Financial Bloggers
Top 25 Corporate Insiders
Top 25 Hedge Fund Managers
Top Individual Investors
New
News
News
Categories
Home
Market News
TipRanks Labs
Ideas & Insights
Stock Analysis
Trending Topics
Coronavirus Stocks
Dividend Stocks
Penny Stocks
FAANG Stocks
Calendars
Calendars
Calendars & Events
Earnings Calendars
Dividend Calendars
Stock Market Holidays
IPO Calendar
Plans & Pricing
News
Smart Portfolio
Markets
Notifications
All News
SRNE
Topic
Sorrento: New Platform Further Underscores the Bull Case
Not content with boasting a pipeline bursting at the seams with multiple candidates in various stages of development,...
Marty Shtrubel
Feb 09, 2021
SRNE
Sorrento: Breaking Down B. Riley’s New Bullish Call
Diversifying a portfolio is often cited as a safe investing strategy, but it is also the game plan...
Marty Shtrubel
Feb 01, 2021
SRNE
Sorrento Stock Has Multiple Catalysts in Play; Analyst Says ‘Buy’
Some companies favor a “do one job and do it well” approach. However, that is not the Sorrento...
Marty Shtrubel
Jan 25, 2021
SRNE
Sorrento Stock Could Hit $30, Says Analyst
The major U.S. equity-indexes are hovering around all-time highs, and a question that frequently pops up these days,...
Marty Shtrubel
Jan 15, 2021
SRNE
Sorrento Pops 8% Pre-Market On FDA Application For Covid-19 Test
Shares of Sorrento Therapeutics spiked 8% in Wednesday’s pre-market trading after the drugmaker filed for emergency use of...
Sharon Wrobel
Dec 23, 2020
SRNE
Sorrento Adds Stem Cell Treatment To Covid-19 Pipeline; Shares Rise
Shares in Sorrento rose 2.7% in Monday’s extended market session after the company entered into an exclusive license...
Sharon Wrobel
Oct 13, 2020
SRNE
If COVID-19 Antibody ‘Cocktails’ Become Popular, Sorrento Stock Could Double, Says Analyst
Once a specialist in oncology drugs and pain management, Sorrento Therapeutics (SRNE) has pivoted to attack COVID-19 head-on...
TipRanks Team
Oct 06, 2020
SRNE
Is Sorrento Stock a Buy Right Now? This Is What You Need to Know
Sorrento Therapeutics (SRNE) has taken a unique approach to fighting the coronavirus. While most pharma companies taking the...
Marty Shtrubel
Sep 28, 2020
SRNE
Sorrento Spikes 11% On Positive RTX Epidural Data In Cancer Patients
Shares in Sorrento Therapeutics (SRNE) spiked 10.51% in Tuesday’s trading after the company released positive Phase 1b Study results...
Harriet Lefton
Sep 23, 2020
SRNE
Sorrento Pops 28% On FDA Nod To Kick Off Covid-19 Antibody Trial
Shares in Sorrento are surging 28% in Thursday’s pre-market session after the biotech company said it received US...
Sharon Wrobel
Sep 17, 2020
SRNE
Sorrento Stock Is Dashing Towards a Brighter Future, Says Analyst
The coronavirus has thrust many previously unknown pharma companies into the spotlight. You can certainly place Sorrento Therapeutics...
Marty Shtrubel
Aug 31, 2020
SRNE
Sorrento Ties The Knot With SmartPharm, Boosting Its Covid-19 Offering
Sorrento Therapeutics (SRNE) and SmartPharm Therapeutics have now signed a merger agreement for Sorrento to acquire SmartPharm, a...
Harriet Lefton
Aug 21, 2020
SRNE
Sorrento Dives 14% In Extended Trading After CFO Ousted
Sorrento sank 14% in extended market trading after the biotech company announced the ousting of its chief financial...
Sharon Wrobel
Aug 19, 2020
SRNE
2 Top Coronavirus Stocks with Massive Upside Potential
Anywhere you turn, COVID-19’s impact can be seen. The deadly virus’ romp around the world and the lockdowns...
Maya Sasson
Aug 09, 2020
NVAX
SRNE
Sorrento’s New COVID-19 Test Could Be a Game Changer, Says 5-Star Analyst
Sorrento Therapeutics (SRNE) enjoyed yet another stellar day. Sure, there have been plenty of good weeks so far...
Marty Shtrubel
Aug 03, 2020
SRNE
Sorrento To Buy SmartPharm For Potential Covid-19 Treatment; Top Analyst Says Buy
Sorrento (SRNE) has signed of a letter of intent to buy SmartPharm, to develop a pipeline of gene-encoded...
Sharon Wrobel
Jul 26, 2020
SRNE
Upcoming Phase 2 COVID-19 Trial Marks Key Milestone for Sorrento (SRNE); Analyst Says ‘Buy’
A journey of a thousand miles begins with a single step, and a big one in this case....
Marty Shtrubel
Jul 24, 2020
SRNE
Can This Coronavirus Stock Soar 230%? 5-Star Analyst Thinks So
Diversification is a tried-and-true strategy when investing in stocks. Drug maker Sorrento Therapeutics (SRNE) is applying the same...
Marty Shtrubel
Jul 09, 2020
SRNE
Sorrento Edges Higher On Debt Repayment As Top Analyst Says Buy
Shares in Sorrento Therapeutics (SRNE) edged 5% higher in Friday’s after-hours trading, after the company announced that it...
Harriet Lefton
Jun 14, 2020
SRNE
Sorrento Soars 17% In Pre-Market On Covid-19 Test Application
Shares in Sorrento (SRNE) are rallying 17% in Thursday’s pre-market trading after the company announced that an Application...
Harriet Lefton
Jun 11, 2020
SRNE
Top Analyst Sees More Than One Path to COVID-19 Solutions for Sorrento
Sorrento Therapeutics’ (SRNE) competitors might be further down the line with their COVID-19 programs, but H.C. Wainwright analyst...
Marty Shtrubel
Jun 10, 2020
SRNE
Sorrento’s COVID-19 Cocktail Could Drive Major Upside, Says Analyst
Will a single antibody be enough to stomp out a COVID-19 infection? Sorrento Therapeutics (SRNE) says no. Rather,...
Maya Sasson
Jun 08, 2020
SRNE
Sorrento Takes Another Leap Forward with Recent FDA Clearance, Says Top Analyst
And the W’s just keep on coming for Sorrento Therapeutics (SRNE). Reflecting a major step forward in the...
Maya Sasson
May 27, 2020
SRNE
Sorrento’s COVID-19 Antidote Could be a Game Changer, Says Analyst
How do we protect those at the frontline facing COVID-19 head on? Sorrento Therapeutics (SRNE) is on it....
Maya Sasson
May 26, 2020
SRNE
Sorrento (SRNE) Stock Is up 140% in Two Days. How Much Higher Can It Go?
Head back to Thursday’s market close and shares of drug maker Sorrento Therapeutics (SRNE) were trading for $2.62,...
Marty Shtrubel
May 18, 2020
SRNE
You need to enable JavaScript to run this app.